Advertisement

Journal of Autism and Developmental Disorders

, Volume 45, Issue 6, pp 1541–1568 | Cite as

Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biological Theory and Approach

  • Noha F. Minshawi
  • Sarah Hurwitz
  • Danielle Morriss
  • Christopher J. McDougle
Original Paper

Abstract

The objective of this review is to consider the psychological (largely behavioral) and biological [neurochemical, medical (including genetic), and pharmacological] theories and approaches that contribute to current thinking about the etiology and treatment of self-injurious behavior (SIB) in individuals with autism spectrum disorder and/or intellectual disability. Algorithms for the assessment and treatment of SIB in this context, respectively, from a multidisciplinary, integrative perspective are proposed and challenges and opportunities that exist in clinical and research settings are discussed.

Keywords

Autism spectrum disorder Intellectual disability Self-injurious behavior Behavior therapy Pharmacotherapy 

References

  1. Aboitiz, F., Scheibel, A. B., Fisher, R. S., & Zaidel, E. (1992). Individual differences in brain asymmetries and fiber composition in the human corpus callosum. Brain Research, 598(1), 154–161.PubMedGoogle Scholar
  2. Adamson, W. C., Nellis, B. P., Runge, G., Cleland, C., & Killian, E. (1958). Use of tranquilizers for mentally deficient patients. Archives of Pediatrics and Adolescent Medicine, 96(2), 159–164.Google Scholar
  3. Aghajanian, G. K., & Sanders-Bush, E. (2002). Serotonin. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 15–34). Philidelphia, PA: Lippincott Williams & Wilkins.Google Scholar
  4. Alexander, A. L., Lee, J. E., Lazar, M., Boudos, R., DuBray, M. B., Oakes, T. R., et al. (2007). Diffusion tensor imaging of the corpus callosum in autism. Neuroimage, 34(1), 61–73.PubMedGoogle Scholar
  5. Aman, M. G. (1993). Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities. Annals of Clinical Psychiatry, 5(3), 171–188.PubMedGoogle Scholar
  6. Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., & Findling, R. L. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. The American Journal of Psychiatry, 159(8), 1337–1346.PubMedGoogle Scholar
  7. Aman, M. G., Kasper, W., Manos, G., Mathew, S., Marcus, R., Owen, R., et al. (2010). Line-item analysis of the Aberrant Behavior Checklist: Results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 20(5), 415–422.PubMedGoogle Scholar
  8. Aman, M. G., & Madrid, A. (1999). Atypical antipsychotics in persons with developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5(4), 253–263.Google Scholar
  9. Aman, M. G., McDougle, C. J., Scahill, L., Handen, B., Arnold, L. E., Johnson, C., et al. (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(12), 1143–1154.PubMedGoogle Scholar
  10. Aman, M. G., Teehan, C. J., White, A. J., Turbott, S. H., & Vaithianathan, C. (1989). Haloperidol treatment with chronically medicated residents: Dose effects on clinical behavior and reinforcement contingencies. American Journal of Mental Retardation, 93(4), 452–460.PubMedGoogle Scholar
  11. Aman, M. G., & White, A. J. (1988). Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents. Journal of Autism and Developmental Disorders, 18(3), 355–366.PubMedGoogle Scholar
  12. Anderson, L. T., & Ernst, M. (1994). Self-injury in Lesch-Nyhan disease. Journal of Autism and Developmental Disorders, 24(1), 67–81.PubMedGoogle Scholar
  13. Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., et al. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7(8), 831–836.PubMedGoogle Scholar
  14. Anderson, L. T., Herrmann, L., & Dancis, J. (1976). The effect of L-5-hydroxytryptophan on self-mutilation in Lesch-Nyhan disease: A negative report. Neuropadiatrie, 7(4), 439–442.PubMedGoogle Scholar
  15. Arnold, L. E., Vitiello, B., McDougle, C. J., Scahill, L., Shah, B., Gonzales, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1443–1450.PubMedGoogle Scholar
  16. Arron, K., Oliver, C., Moss, J., Berg, K., & Burbidge, C. (2011). The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. Journal of Intellectual Disability Research, 55(2), 109–120.PubMedGoogle Scholar
  17. Baghdadli, A., Pascal, C., Grisi, S., & Aussilloux, C. (2003). Risk factors for self-injurious behaviours among 222 young children with autistic disorders. Journal of Intellectual Disability Research, 47(8), 622–627.PubMedGoogle Scholar
  18. Baghdadli, A., Picot, M. C., Pry, R., Michelon, C., Burzstejn, C., Lazartigues, A., et al. (2008). What factors are related to a negative outcome of self-injurious behaviour during childhood in pervasive developmental disorders? Journal of Applied Research in Intellectual Disabilities, 21(2), 142–149.Google Scholar
  19. Baldessarini, R. J., & Frankenburg, F. R. (1991). Clozapine: A novel antipsychotic agent. The New England Journal of Medicine, 324(11), 746–754.PubMedGoogle Scholar
  20. Barrera, F. J., Violo, R. A., & Graver, E. E. (2007). On the form and function of severe self-injurious behavior. Behavioral Interventions, 22(1), 5–33.Google Scholar
  21. Baumeister, A. A., & Frye, G. D. (1984). Self-injurious behavior in rats produced by intranigral microinjection of GABA agonists. Pharmacology, Biochemistry and Behavior, 21(1), 89–95.PubMedGoogle Scholar
  22. Baumeister, A. A., & Frye, G. D. (1985). The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome. Neuroscience and Biobehavioral Reviews, 9(2), 169–178.PubMedGoogle Scholar
  23. Baxter, C., Cummins, R. A., & Yiolitis, L. (2000). Parental stress attributed to family members with and without intellectual disability: A longitudinal study. Journal of Intellectual and Developmental Disability, 25(2), 105–118.Google Scholar
  24. Beadle-Brown, J., Murphy, G., & Wing, L. (2005). Long-term outcome for people with severe intellectual disabilities: Impact of social impairment. American Journal of Mental Retardation, 110(1), 1–12.PubMedGoogle Scholar
  25. Bear, D., Levin, K., Blumer, D., Chetham, D., & Ryder, J. (1982). Interictal behaviour in hospitalised temporal lobe epileptics: Relationship to idiopathic psychiatric syndromes. Journal of Neurology, Neurosurgery and Psychiatry, 45(6), 481–488.PubMedCentralPubMedGoogle Scholar
  26. Bitsika, V., & Sharpley, C. F. (2004). Stress, anxiety and depression among parents of children with autism spectrum disorder. Australian Journal of Guidance and Counselling, 14(2), 151–161.Google Scholar
  27. Blacher, J., Lopez, S., Shapiro, J., & Fusco, J. (1997). Contributions to depression in latina mothers with and without children with retardation: Implications for caregiving. Family Relations, 46(4), 325–334.Google Scholar
  28. Blake, B. L., Muehlmann, A. M., Egami, K., Breese, G. R., Devine, D. P., & Jinnah, H. A. (2007). Nifedipine suppresses self-injurious behaviors in animals. Developmental Neuroscience, 29(3), 241–250.PubMedCentralPubMedGoogle Scholar
  29. Blatt, G. J. (2011). The GABA system in autism. In E. Hollander, A. Kolevzon, & J. T. Coyle (Eds.), Textbook of autism spectrum disorders (pp. 323–326). Washington, DC: American Psychiatric Publishing Inc.Google Scholar
  30. Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001). Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. Journal of Autism and Developmental Disorders, 31(6), 537–543.PubMedGoogle Scholar
  31. Bloch, M. R., Elliott, M., Thompson, H., & Koran, L. M. (2001). Fluoxetine in pathologic skin-picking: Open-label and double-blind results. Psychosomatics, 42(4), 314–319.PubMedGoogle Scholar
  32. Blumer, D. (2000). Dysphoric disorders and paroxysmal affects: Recognition and treatment of epilepsy-related psychiatric disorders. Harvard Review of Psychiatry, 8(1), 8–17.PubMedGoogle Scholar
  33. Borrero, J. C., Vollmer, T. R., Wright, C. S., Lerman, D. C., & Kelley, M. E. (2002). Further evaluation of the role of protective equipment in the functional analysis of self-injurious behavior. Journal of Applied Behavior Analysis, 35(1), 69–72.PubMedCentralPubMedGoogle Scholar
  34. Bosch, J., Van Dyke, C., Smith, S. M., & Poulton, S. (1997). Role of medical conditions in the exacerbation of self-injurious behavior: An exploratory study. Mental Retardation, 35(2), 124–130.PubMedGoogle Scholar
  35. Boyer, W. F., & Feighner, J. P. (1992). An overview of paroxetine. The Journal of Clinical Psychiatry, 53, 3–6.PubMedGoogle Scholar
  36. Brahm, N. C., Fast, G. A., & Brown, R. C. (2008). Buspirone for autistic disorder in a woman with an intellectual disability. The Annals of Pharmacotherapy, 42(1), 131–137.PubMedGoogle Scholar
  37. Brandt, B. R., & Rosen, I. (1998). Impaired peripheral somatosensory function in children with Prader-Willi syndrome. Neuropediatrics, 29(3), 124–126.PubMedGoogle Scholar
  38. Breau, L. M., Camfield, C. S., Symons, F. J., Bodfish, J. W., Mackay, A., Finley, G. A., et al. (2003). Relation between pain and self-injurious behavior in nonverbal children with severe cognitive impairments. The Journal of Pediatrics, 142(5), 498–503.PubMedGoogle Scholar
  39. Breau, L. M., McGrath, P. J., Camfield, C., Rosmus, C., & Finley, G. A. (2000). Preliminary validation of an observational pain checklist for persons with cognitive impairments and inability to communicate verbally. Developmental Medicine and Child Neurology, 42(9), 609–616.PubMedGoogle Scholar
  40. Breese, G. R., Baumeister, A. A., McCown, T. J., Emerick, S. G., Frye, G. D., Crotty, K., et al. (1984). Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. The Journal of Pharmacology and Experimental Therapeutics, 231(2), 343–354.PubMedCentralPubMedGoogle Scholar
  41. Breese, G. R., Criswell, H. E., Duncan, G. E., & Mueller, R. A. (1990). A dopamine deficiency model of Lesch-Nyhan disease: The neonatal-6-OHDA-lesioned rat. Brain Research Bulletin, 25(3), 477–484.PubMedGoogle Scholar
  42. Bruhl, H. H., Fielding, L., Joyce, M., Peters, W., & Wieseler, N. (1982). Thirty-month demonstration project for treatment of self-injurious behavior in severely retarded individuals. Monographs of the American Association on Mental Deficiency, 5, 191–275.PubMedGoogle Scholar
  43. Brylewski, J., & Wiggs, L. (1999). Sleep problems and daytime challenging behaviour in a community-based sample of adults with intellectual disability. Journal of Intellectual Disability Research, 43(6), 504–512.PubMedGoogle Scholar
  44. Buitelaar, J. K. (1993). Self-injurious behaviour in retarded children: Clinical phenomena and biological mechanisms. Acta Paedopsychiatrica, 56(2), 105–111.PubMedGoogle Scholar
  45. Butler, M. G., Bittel, D. C., Kibiryeva, N., Talebizadeh, Z., & Thompson, T. (2004). Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics, 113(3), 565–573.PubMedGoogle Scholar
  46. Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32(6), 1283–1291.PubMedGoogle Scholar
  47. Cancela, L. M., Artinian, J., & Fulginiti, S. (1988). Opioid influence on some aspects of stereotyped behavior induced by repeated amphetamine treatment. Pharmacology, Biochemistry and Behavior, 30(4), 899–904.PubMedGoogle Scholar
  48. Canitano, R. (2006). Self injurious behavior in autism: Clinical aspects and treatment with risperidone. Journal of Neural Transmission, 113(3), 425–431.PubMedGoogle Scholar
  49. Carr, J. E., Coriaty, S., Wilder, D. A., Gaunt, B. T., Dozier, C. L., Britton, L. N., et al. (2000). A review of “noncontingent” reinforcement as treatment for the aberrant behavior of individuals with developmental disabilities. Research in Developmental Disabilities, 21(5), 377–391.PubMedGoogle Scholar
  50. Carr, E. G., & LeBlanc, L. A. (2003). Functional analysis of problem behavior. In W. Donahue, J. E. Fishers, & S. C. Hayes (Eds.), Cognitive behavior therapy: Applying empirically supported techniques in your practice. Hoboken, NJ: Wiley.Google Scholar
  51. Carr, J. E., Severtson, J. M., & Lepper, T. L. (2009). Noncontingent reinforcement is an empirically supported treatment for problem behavior exhibited by individuals with developmental disabilities. Research in Developmental Disabilities, 30(1), 44–57.PubMedGoogle Scholar
  52. Carr, E. G., & Smith, C. E. (1995). Biological setting events for self-injury. Mental Retardation and Developmental Disabilities Research Reviews, 1(2), 94–98.Google Scholar
  53. Carr, E. G., Smith, C. E., Giacin, T. A., Whelan, B. M., & Pancari, J. (2003). Menstrual discomfort as a biological setting event for severe problem behavior: Assessment and intervention. American Journal of Mental Retardation, 108(2), 117–133.PubMedGoogle Scholar
  54. Carroll, M. N., & Lim, R. K. (1960). Observations on the neuropharmacology of morphine and morphinelike analgesia. Archives Internationales de Pharmacodynamie et de Therapie, 125, 383–403.PubMedGoogle Scholar
  55. Cassidy, S. B. (1997). Prader-Willi syndrome. Journal of Medical Genetics, 34(11), 917–923.PubMedCentralPubMedGoogle Scholar
  56. Cassidy, S. B., & Driscoll, D. J. (2009). Prader-Willi syndrome. European Journal of Human Genetics, 17(1), 3–13.PubMedCentralPubMedGoogle Scholar
  57. Cassidy, S. B., Schwartz, S., Miller, J. L., & Driscoll, D. J. (2012). Prader-Willi syndrome. Genetics in Medicine, 14(1), 10–26.PubMedGoogle Scholar
  58. Clarke, S., Dunlap, G., & Vaughn, B. (1999). Family-centered, assessment-based intervention to improve behavior during an early morning routine. Journal of Positive Behavior Interventions, 1(4), 235–241.Google Scholar
  59. Codling, M., & MacDonald, N. (2009). Epilepsy: Implications for people with profound intellectual and multiple disabilities. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 134–146). Hoboken: Wiley.Google Scholar
  60. Coffey, M. J. (2013). Resolution of self-injury with phenytoin in a man with autism and intellectual disability: The role of frontal lobe seizures and catatonia. Journal of ECT, 29(1), 12–13.Google Scholar
  61. Cohen, S. A., & Underwood, M. T. (1994). The use of clozapine in a mentally retarded and aggressive population. Journal of Clinical Psychiatry, 55(10), 440–444.PubMedGoogle Scholar
  62. Collins, M. S., & Cornish, K. (2002). A survey of the prevalence of stereotypy, self-injury and aggression in children and young adults with Cri du Chat syndrome. Journal of Intellectual Disability Research, 46(2), 133–140.PubMedGoogle Scholar
  63. Consoli, A., Cohen, J., Bodeau, N., Guinchat, V., Wachtel, L., & Cohen, D. (2013). Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: A retrospective study. European Child and Adolescent Psychiatry, 22(1), 55–62.PubMedGoogle Scholar
  64. Conti, F., & Manzoni, T. (1994). The neurotransmitters and postsynaptic actions of callosally projecting neurons. Behavioural Brain Research, 64(1), 37–53.PubMedGoogle Scholar
  65. Cooper, A. F., & Fowlie, H. C. (1973). Control of gross self-mutilation with lithium carbonate. The British Journal of Psychiatry, 122(568), 370–371.PubMedGoogle Scholar
  66. Cooper, J. O., Heron, T. E., & Heward, W. L. (2007). Applied behavior analysis. New Jersey: Pearson Education Inc.Google Scholar
  67. Cooper, S. A., Smiley, E., Allan, L. M., Jackson, A., Finlayson, J., Mantry, D., et al. (2009). Adults with intellectual disabilities: Prevalence, incidence and remission of self-injurious behaviour, and related factors. Journal of Intellectual Disability Research, 53(3), 200–216.PubMedGoogle Scholar
  68. Cornish, K. M., Bramble, D., Munir, F., & Pigram, J. (1999). Cognitive functioning in children with typical cri du chat (5p-) syndrome. Developmental Medicine and Child Neurology, 41(4), 263–266.PubMedGoogle Scholar
  69. Courtemanche, A., Schroeder, S., Sheldon, J., Sherman, J., & Fowler, A. (2012). Observing signs of pain in relation to self-injurious behaviour among individuals with intellectual and developmental disabilities. Journal of Intellectual Disability Research, 56(5), 501–515.PubMedGoogle Scholar
  70. Crawford, H. (2009). Dysphagia and people with profound intellectual and multiple disabilities. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 236–258). Hoboken: Wiley.Google Scholar
  71. Crockett, C. M., Sackett, G. P., Sandman, C. A., Chicz-DeMet, A., & Bentson, K. L. (2007). Beta-endorphin levels in longtailed and pigtailed macaques vary by abnormal behavior rating and sex. Peptides, 28(10), 1987–1997.PubMedCentralPubMedGoogle Scholar
  72. Crossland, S., Burns, M., Leach, C., & Quinn, P. (2005). Needs assessment in forensic learning disability. Medicine, Science and the Law, 45(2), 147–153.Google Scholar
  73. Czapinski, P., Blaszczyk, B., & Czuczwar, S. J. (2005). Mechanisms of action of antiepileptic drugs. Current Topics in Medicinal Chemistry, 5(1), 3–14.PubMedGoogle Scholar
  74. Davanzo, P. A., Belin, T. R., Widawski, M. H., & King, B. H. (1998). Paroxetine treatment of aggression and self-injury in persons with mental retardation. American Journal of Mental Retardation, 102(5), 427–437.PubMedGoogle Scholar
  75. Davanzo, P. A., & King, B. H. (1996). Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. Journal of Child and Adolescent Psychopharmacology, 6(4), 273–279.PubMedGoogle Scholar
  76. Davis, K. V., Sprague, R. L., & Werry, J. S. (1969). Stereotyped behavior and activity level in severe retardates: The effect of drugs. American Journal of Mental Deficiency, 73(5), 721–727.PubMedGoogle Scholar
  77. de Winter, C. F., Jansen, A. A., & Evenhuis, H. M. (2011). Physical conditions and challenging behaviour in people with intellectual disability: A systematic review. Journal of Intellectual Disability Research, 55(7), 675–698.PubMedGoogle Scholar
  78. Deb, S., Thomas, M., & Bright, C. (2001). Mental disorder in adults with intellectual disability. 2: The rate of behaviour disorders among a community-based population aged between 16 and 64 years. Journal of Intellectual Disability Research, 45(6), 506–514.PubMedGoogle Scholar
  79. DeLeon, I. G., Fisher, W. W., & Marhefka, J. M. (2004). Decreasing self-injurious behavior associated with awakening in a child with autism and developmental delays. Behavioral Interventions, 19(2), 111–119.Google Scholar
  80. Didden, R., Korzilius, H., & Curfs, L. M. (2007). Skin-picking in individuals with Prader-Willi syndrome: Prevalence, functional assessment, and its comorbidity with compulsive and self-injurious behaviours. Journal of Applied Research in Intellectual Disabilities, 20(5), 409–419.Google Scholar
  81. Dooley, P., Wilczenski, F. L., & Torem, C. (2001). Using an activity schedule to smooth school transitions. Journal of Positive Behavior Interventions, 3(1), 57–61.Google Scholar
  82. Dove, D., Warren, Z., McPheeters, M. L., Taylor, J. L., Sathe, N. A., & Veenstra-VanderWeele, J. (2012). Medications for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130(4), 717–726.PubMedCentralPubMedGoogle Scholar
  83. Duerden, E. G., Oatley, H. K., Mak-Fan, K. M., McGrath, P. A., Taylor, M. J., Szatmari, P., et al. (2012). Risk factors associated with self-injurious behaviors in children and adolescents with autism spectrum disorders. Journal of Autism and Developmental Disorders, 42(11), 2460–2470.PubMedGoogle Scholar
  84. Duker, P. C. (1975). Use of aversive shock therapy on a retarded girl with self destructive behaviors. Zeitschrift für Klinische Psychologie, 4(1), 38–47.Google Scholar
  85. Duncan, D., Matson, J. L., Bamburg, J. W., Cherry, K. E., & Buckley, T. (1999). The relationship of self-injurious behavior and aggression to social skills in persons with severe and profound learning disability. Research in Developmental Disabilities, 20(6), 441–448.PubMedGoogle Scholar
  86. Dykens, E. M., Cassidy, S. B., & King, B. H. (1999). Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. American Journal on Mental Retardation, 104(1), 67–77.PubMedGoogle Scholar
  87. Eidelberg, E., & Erspamer, R. (1975). Dopaminergic mechanisms of opiate actions in brain. The Journal of Pharmacology and Experimental Therapeutics, 192(1), 50–57.PubMedGoogle Scholar
  88. Engel, J., & Berggren, U. (1980). Effects of lithium on behaviour and central monoamines. Acta Psychiatrica Scandinavica, 280, S133–S143.Google Scholar
  89. Ernst, M. (2000). Commentary: Considerations on the characterization and treatment of self-injurious behavior. Journal of Autism and Developmental Disorders, 30(5), 447–450.PubMedGoogle Scholar
  90. Espie, C. A., Watkins, J., Curtice, L., Espie, A., Duncan, R., Ryan, J. A., et al. (2003). Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. Journal of Neurology, Neurosurgery and Psychiatry, 74(11), 1485–1492.PubMedCentralPubMedGoogle Scholar
  91. Farber, J. M. (1987). Psychopharmacology of self-injurious behavior in the mentally retarded. Journal of the American Academy of Child and Adolescent Psychiatry, 26(3), 296–302.PubMedGoogle Scholar
  92. Fatemi, S. H., Folsom, T. D., Reutiman, T. J., & Thuras, P. D. (2009). Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum, 8(1), 64–69.PubMedCentralPubMedGoogle Scholar
  93. Fisher, W. W., Groff, R. A., & Roane, H. S. (2011). Applied behavior analysis. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 3–16). New York: Guilford Press.Google Scholar
  94. Fontenot, M. B., Musso, M. W., McFatter, R. M., & Anderson, G. M. (2009). Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta). Journal of the American Association for Laboratory Animal Science, 48(2), 176–184.PubMedCentralPubMedGoogle Scholar
  95. Fontenot, M. B., Padgett, E. E, I. I. I., Dupuy, A. M., Lynch, C. R., De Petrillo, P. B., & Higley, J. D. (2005). The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. Comparative Medicine, 55(1), 67–74.PubMedGoogle Scholar
  96. Garber, H. J., McGonigle, J. J., Slomka, G. T., & Monteverde, E. (1992). Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. Journal of the Amercian Academy of Child and Adolescent Psychiatry, 31(6), 1157–1160.Google Scholar
  97. Glick, I. D., Murray, S. R., Vasudevan, P., Marder, S. R., & Hu, R. J. (2001). Treatment with atypical antipsychotics: New indications and new populations. Journal of Psychiatric Research, 35(3), 187–191.PubMedGoogle Scholar
  98. Goldstein, M. (1989). Dopaminergic mechanisms in self-inflicting biting behavior. Psychopharmacology Bulletin, 25(3), 349–352.PubMedGoogle Scholar
  99. Goldstein, M., Anderson, L. T., Reuben, R., & Dancis, J. (1985). Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation. Lancet, 1(8424), 338–339.PubMedGoogle Scholar
  100. Gossler, A., Schalamon, J., Huber-Zeyringer, A., & Hollwarth, M. E. (2007). Gastroesophageal reflux and behavior in neurologically impaired children. Journal of Pediatric Surgery, 42(9), 1486–1490.PubMedGoogle Scholar
  101. Granger, P., Biton, B., Faure, C., Vige, X., Depoortere, H., Graham, D., et al. (1995). Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Molecular Pharmacology, 47(6), 1189–1196.PubMedGoogle Scholar
  102. Greenberg, A., & Coleman, M. (1973). Depressed whole blood serotonin levels associated with behavioral abnormalities in the de Lange syndrome. Pediatrics, 52(5), 720–724.PubMedGoogle Scholar
  103. Gualtieri, C. T. (1989). The differential diagnosis of self-injurious behavior in mentally retarded people. Psychopharmacology Bulletin, 25(3), 358–363.PubMedGoogle Scholar
  104. Gualtieri, C. T., & Schroeder, S. R. (1989). Pharmacotherapy for self-injurious behavior: Preliminary tests of the D1 hypothesis. Psychopharmacology Bulletin, 25(3), 364–371.PubMedGoogle Scholar
  105. Guptill, J. T., Booker, A. B., Gibbs, T. T., Kemper, T. L., Bauman, M. L., & Blatt, G. J. (2007). [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: A multiple concentration autoradiographic study. Journal of Autism and Developmental Disorders, 37(5), 911–920.PubMedGoogle Scholar
  106. Hammock, R., Levine, W. R., & Schroeder, S. R. (2001). Brief report: Effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. Journal of Autism and Developmental Disorders, 31(1), 109–113.PubMedGoogle Scholar
  107. Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Archives of General Psychiatry, 34(5), 521–531.PubMedGoogle Scholar
  108. Hardan, A. Y., Minshew, N. J., & Keshavan, M. S. (2000). Corpus callosum size in autism. Neurology, 55(7), 1033–1036.PubMedGoogle Scholar
  109. Hassiotis, A., Parkes, C., Jones, L., Fitzgerald, B., & Romeo, R. (2008). Individual characteristics and service expenditure on challenging behaviour for adults with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 21(5), 438–445.Google Scholar
  110. Hedges, D., Jeppson, K., & Whitehead, P. (2003). Antipsychotic medication and seizures: A review. Drugs Today, 39(7), 551–557.PubMedGoogle Scholar
  111. Hellings, J. A., & Warnock, J. K. (1994). Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacology Bulletin, 30(2), 245–250.PubMedGoogle Scholar
  112. Hellings, J. A., Weckbaugh, M., Nickel, E. J., Cain, S. E., Zarcone, J. R., Reese, R. M., et al. (2005). A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15(4), 682–692.PubMedGoogle Scholar
  113. Hollander, E., Wasserman, S., Swanson, E. N., Chaplin, W., Schapiro, M. L., Zagursky, K., et al. (2006). A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology, 16(5), 541–548.PubMedGoogle Scholar
  114. Holson, R. R., Scallet, A. C., Ali, S. F., Sullivan, P., & Gough, B. (1988). Adrenocortical, beta-endorphin and behavioral responses to graded stressors in differentially reared rats. Physiology & Behavior, 42(2), 125–130.Google Scholar
  115. Horner, R. H., Day, H. M., & Day, J. R. (1997). Using neutralizing routines to reduce problem behaviors. Journal of Applied Behavior Analysis, 30(4), 601–614.PubMedCentralPubMedGoogle Scholar
  116. Horner, R. H., Day, H. M., Sprague, J. R., & O’Brien, M. (1991). Interspersed requests: A nonaversive procedure for reducing aggression and self-injury during instruction. Journal of Applied Behavior Analysis, 24(2), 265–278.PubMedCentralPubMedGoogle Scholar
  117. Horsthemke, B., & Wagstaff, J. (2008). Mechanisms of imprinting of the Prader-Willi/Angelman region. American Journal of Medical Genetics, 146A(16), 2041–2052.PubMedGoogle Scholar
  118. Hurwitz, S., & Minshawi, N. (2012). Methods of defining and observing behaviors. In J. L. Matson (Ed.), Functional assessment for challenging behaviors (pp. 91–103). New York: Springer Science + Business Media LLC.Google Scholar
  119. Iwata, B. A., Dorsey, M. F., Slifer, K. J., & Bauman, K. E. (1994a). Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis, 27(2), 197–209.PubMedCentralPubMedGoogle Scholar
  120. Iwata, B. A., Pace, G. M., Dorsey, M. F., & Zarcone, J. R. (1994b). The functions of self-injurious behavior: An experimental-epidemiological analysis. Journal of Applied Behavior Analysis, 27(2), 215–240.PubMedCentralPubMedGoogle Scholar
  121. Iwata, B. A., Pace, G. M., Kalsher, M. J., & Cowdery, G. E. (1990a). Experimental analysis and extinction of self-injurious escape behavior. Journal of Applied Behavior Analysis, 23(1), 11–27.PubMedCentralPubMedGoogle Scholar
  122. Iwata, B. A., Vollmer, T. R., & Zarcone, J. R. (1990b). The experimental (functional) analysis of behavior disorders: Methodology, applications, and limitations. In A. C. Repp (Ed.), Perspectives on the use of nonaversive and aversive interventions for persons with developmental disabilities (pp. 301–330). Illinois: Sycamore Publishing Company.Google Scholar
  123. Jankovic, J., Caskey, T. C., Stout, J. T., & Butler, I. J. (1988). Lesch-Nyhan syndrome: A study of motor behavior and cerebrospinal fluid neurotransmitters. Annals of Neurology, 23(5), 466–469.PubMedGoogle Scholar
  124. Janowsky, D. S., Barnhill, L. J., & Davis, J. M. (2003). Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: A retrospective, open-label, naturalistic trial. The Journal of Clinical Psychiatry, 64(10), 1258–1265.PubMedGoogle Scholar
  125. Janowsky, D. S., Barnhill, L. J., Shetty, M., & Davis, J. M. (2005). Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults. Journal of Clinical Psychopharmacology, 25(1), 19–25.PubMedGoogle Scholar
  126. Jennett, H., Hagopian, L. P., & Beaulieu, L. (2011). Analysis of heart rate and self-injury with and without restraint in an individual with autism. Research in Autism Spectrum Disorders, 5(3), 1110–1118.Google Scholar
  127. Jinnah, H. A., Gage, F. H., & Friedmann, T. (1990). Animal models of Lesch-Nyhan syndrome. Brain Research Bulletin, 25(3), 467–475.PubMedGoogle Scholar
  128. Jinnah, H. A., Vissar, J. E., Harris, J. C., Verdu, A., Larovere, L., Ceballos-Piscot, I., et al. (2006). Delineation of the motor disorder of Lesch-Nyhan disease. Brain, 129(5), 1201–1217.PubMedCentralPubMedGoogle Scholar
  129. Jordan, I., Robertson, D., Catani, M., Craig, M., & Murphy, D. (2012). Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder. Psychopharmacology (Berl), 223(3), 357–360.Google Scholar
  130. Kaplan, G. B., & Leite-Morris, B. S. (2002). Introduction to neuronal signaling pathways. In G. B. Kaplan & R. P. Hammer (Eds.), Brain circuitry and signaling in psychiatry (pp. 31–62). Washington, DC: American Psychiatric Publishing Inc.Google Scholar
  131. Kelley, M. E., LaRue, R. H., Roane, H. S., & Gadaire, D. M. (2011). Indirect behavioral assessments: Interviews and rating scales. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 182–205). New York: Guilford Press.Google Scholar
  132. Kemp, A. S., Fillmore, P. T., Lenjavi, M. R., Lyon, M., Chicz-Demet, A., Touchette, P. E., et al. (2008). Temporal patterns of self-injurious behavior correlate with stress hormone levels in the developmentally disabled. Psychiatry Research, 157(1), 181–189.PubMedCentralPubMedGoogle Scholar
  133. Kern, L., Gallagher, P., Starosta, K., Hickman, W., & George, M. (2006). Longitudinal outcomes of functional behavioral assessment-based intervention. Journal of Positive Behavior Interventions, 8(2), 67–78.Google Scholar
  134. King, B. H. (1993). Self-injury by people with mental retardation: A compulsive behavior hypothesis. American Journal of Mental Retardation, 98(1), 93–112.PubMedGoogle Scholar
  135. King, B. H. (2000). Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 30(5), 439–445.PubMedGoogle Scholar
  136. King, B. H., Cromwell, H. C., Lee, H. T., Behrstock, S. P., Schmanke, T., & Maidment, N. T. (1998). Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Developmental Neuroscience, 20(2–3), 180–187.PubMedGoogle Scholar
  137. Knapp, M., Comas-Herrera, A., Astin, J., Beecham, J., & Pendaries, C. (2005). Intellectual disability, challenging behaviour and cost in care accommodation: What are the links? Health and Social Care in the Community, 13(4), 297–306.PubMedGoogle Scholar
  138. Kraemer, G. W., & Clarke, A. S. (1990). The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14, S141–S168.PubMedGoogle Scholar
  139. La Malfa, G. P., Bertelli, M., Ricca, V., Mannucci, E., & Cabras, P. L. (1997). Fluvoxamine and mental retardation: Clinical use. Italian Journal of Intellective Impairment, 10, 3–6.Google Scholar
  140. Lakin, K. C., Hill, B. K., Hauber, F. A., Bruininks, R. H., & Heal, L. W. (1983). New admissions and readmissions to a national sample of public residential facilities. American Journal of Mental Deficiency, 88, 13–20.Google Scholar
  141. Le Vann, L. J. (1971). Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. American Journal of Mental Deficiency, 75(6), 719–723.PubMedGoogle Scholar
  142. Leboyer, M., Bouvard, M. P., Launay, J. M., Recasens, C., Plumet, M. H., Waller-Perotte, D., et al. (1993). Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone. L’Encephale, 19(2), 95–102.Google Scholar
  143. Lecavalier, L., Leone, S., & Wiltz, J. (2006). The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. Journal of Intellectual Disability Research, 50(3), 172–183.PubMedGoogle Scholar
  144. Leite-Morris, K. A., Fukudome, E. Y., & Kaplan, G. B. (2002). Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neuroscience Letters, 317(3), 119–122.PubMedGoogle Scholar
  145. Lejeune, J., Lafourcade, J., Berger, R., Vialatte, J., Boeswillwald, M., Seringe, P., et al. (1963). 3 cases of partial deletion of the short arm of a 5 chromosome. Comptes Rendus Hebdomadaires des Seances de l’Academie des Sciences, 257, 3098–3102.PubMedGoogle Scholar
  146. Lequia, J., Machalicek, W., & Rispoli, M. J. (2012). Effects of activity schedules on challenging behavior exhibited in children with autism spectrum disorders: A systematic review. Research in Autism Spectrum Disorders, 6(1), 480–492.Google Scholar
  147. Lewis, M. H., Bodfish, J. W., Powell, S. B., Parker, D. E., & Golden, R. N. (1996). Clomipramine treatment for self-injurious behavior of individuals with mental retardation: A double-blind comparison with placebo. American Journal of Mental Retardation, 100(6), 654–665.PubMedGoogle Scholar
  148. Lewis, M. H., Gluck, J. P., Beauchamp, A. J., Keresztury, M. F., & Mailman, R. B. (1990). Long-term effects of early social isolation in Macaca mulatta: Changes in dopamine receptor function following apomorphine challenge. Brain Research, 513(1), 67–73.PubMedGoogle Scholar
  149. Lindauer, S. E., DeLeon, I. G., & Fisher, W. W. (1999). Decreasing signs of negative affect and correlated self-injury in an individual with mental retardation and mood disturbances. Journal of Applied Behavior Analysis, 32(1), 103–106.PubMedCentralPubMedGoogle Scholar
  150. Lindberg, J. S., Iwata, B. A., Roscoe, E. M., Worsdell, A. S., & Hanley, G. P. (2003). Treatment efficacy of noncontingent reinforcement during brief and extended application. Journal of Applied Behavior Analysis, 36(1), 1–19.PubMedCentralPubMedGoogle Scholar
  151. Lloyd, K. G., Hornykiewicz, O., Davidson, L., Shannak, K., Farley, I., Goldstein, M., et al. (1981). Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. The New England Journal of Medicine, 305(19), 1106–1111.PubMedGoogle Scholar
  152. Loh, H. H., Brase, D. A., Sampath-Khanna, S., Mar, J. B., Way, E. L., & Li, C. H. (1976). Beta-endorphin in vitro inhibition of striatal dopamine release. Nature, 264(5586), 567–568.PubMedGoogle Scholar
  153. Lotan, M., Ljunggren, E. A., Johnsen, T. B., Defrin, R., Pick, C. G., & Strand, L. I. (2009). A modified version of the non-communicating children pain checklist-revised, adapted to adults with intellectual and developmental disabilities: Sensitivity to pain and internal consistency. The Journal of Pain, 10(4), 398–407.PubMedGoogle Scholar
  154. Luiselli, J. K. (1992). Assessment and treatment of self-injury in a deaf-blind child. Journal of Developmental and Physical Disabilities, 4(3), 219–226.Google Scholar
  155. Luiselli, J. K., Cochran, M. L., & Huber, S. A. (2005). Effects of otitis media on a child with autism receiving behavioral intervention for self-injury. Child & Family Behavior Therapy, 27(2), 51–56.Google Scholar
  156. MacLean, W. E., Tervo, R. C., Hoch, J., Tervo, M., & Symons, F. J. (2010). Self-injury among a community cohort of young children at risk for intellectual and developmental disabilities. The Journal of Pediatrics, 157(6), 979–983.PubMedGoogle Scholar
  157. Magee, S. K., & Ellis, J. (2000). Extinction effects during the assessment of multiple problem behaviors. Journal of Applied Behavior Analysis, 33(3), 313–316.PubMedCentralPubMedGoogle Scholar
  158. Major, C. A., Kelly, B. J., Novak, M. A., Davenport, M. D., Stonemetz, K. M., & Meyer, J. S. (2009). The anxiogenic drug FG7142 increases self-injurious behavior in male rhesus monkeys (Macaca mulatta). Life Sciences, 85(21–22), 753–758.PubMedCentralPubMedGoogle Scholar
  159. Mandell, D. S. (2008). Psychiatric hospitalization among children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 38(6), 1059–1065.PubMedCentralPubMedGoogle Scholar
  160. Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48(11), 1110–1119.PubMedGoogle Scholar
  161. Marholin, D, I. I., Touchette, P. E., & Stewart, R. M. (1979). Withdrawal of chronic chlorpromazine medication: An experimental analysis. Journal of Applied Behavior Analysis, 12(2), 159–171.PubMedCentralPubMedGoogle Scholar
  162. Matson, J. L., Bamburg, J. W., Mayville, E. A., & Khan, I. (1999). Seizure disorders in people with intellectual disability: An analysis of differences in social functioning, adaptive functioning and maladaptive behaviours. Journal of Intellectual Disability Research, 43(6), 531–539.PubMedGoogle Scholar
  163. Matson, J. L., & LoVullo, S. V. (2008). A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders. Behavior Modification, 32(1), 61–76.PubMedGoogle Scholar
  164. Matthews, T., Weston, N., Baxter, H., Felce, D., & Kerr, M. (2008). A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and career stress. Journal of Intellectual Disability Research, 52(2), 163–173.PubMedGoogle Scholar
  165. McDonough, M., Hillery, J., & Kennedy, N. (2000). Olanzapine for chronic, stereotypic self-injurious behaviour: A pilot study in seven adults with intellectual disability. Journal of Intellectual Disability Research, 44(6), 677–684.PubMedGoogle Scholar
  166. McDougle, C. J. (2013). Sounding a wake-up call: Improving the lives of adults with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 52(6), 566–568.PubMedGoogle Scholar
  167. McDougle, C. J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996a). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53(11), 993–1000.PubMedGoogle Scholar
  168. McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996b). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53(11), 1001–1008.PubMedGoogle Scholar
  169. McElroy, S. L., Keck, P. E., Pope, H. G., & Hudson, J. I. (1989). Valproate in psychiatric disorders: Literature review and clinical guidelines. The Journal of Clinical Psychiatry, 50, S23–S29.Google Scholar
  170. McManaman, J., & Tam, D. A. (1999). Gabapentin for self-injurious behavior in Lesch-Nyhan syndrome. Pediatric Neurology, 20(5), 381–382.PubMedGoogle Scholar
  171. McNally, G. P., & Akil, H. (2002). Endogenous opioid peptides and their receptors: Overview and function in pain modulation. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 35–46). New York: Lippincott Williams Wilkins.Google Scholar
  172. Mesibov, G. B., Browder, D. M., & Kirkland, C. (2002). Using individualized schedules as a component of positive behavioral support for students with developmental disabilities. Journal of Positive Behavior Interventions, 4(2), 73–79.Google Scholar
  173. Micev, V., & Lynch, D. M. (1974). Effect of lithium on disturbed severely mentally retarded patients. The British Journal of Psychiatry, 125(584), 110.PubMedGoogle Scholar
  174. Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 749–764.PubMedCentralPubMedGoogle Scholar
  175. Miyamoto, S., Duncan, G. E., Goff, D. C., & Lieberman, J. A. (2002). Therapeutics of schizophrenia. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 777–797). Philidelphia, PA: Lippincott Williams & Wilkins.Google Scholar
  176. Mizuno, T. I., & Yugari, Y. (1974). Letter: Self mutilation in Lesch-Nyhan syndrome. Lancet, 1(7860), 761.PubMedGoogle Scholar
  177. Mizuno, T., & Yugari, Y. (1975). Prophylactic effect of L-5-hydroxytryptophan on self-mutilation in the Lesch-Nyhan syndrome. Neuropadiatrie, 6(1), 13–23.Google Scholar
  178. Moreno-Fuenmayor, H., Borjas, L., Arrieta, A., Valera, V., & Socorro-Candanoza, L. (1996). Plasma excitatory amino acids in autism. Investigacion Clinica, 37(2), 113–128.PubMedGoogle Scholar
  179. Morgan, J. R., Storch, E. A., Woods, D. W., Bodzin, D., Lewin, A. B., & Murphy, T. K. (2010). A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome. Child Psychiatry and Human Development, 41(4), 448–463.PubMedGoogle Scholar
  180. Mori, T., Ito, S., Kita, T., Narita, M., Suzuki, T., Matsubayashi, K., et al. (2007). Oxidative stress in methamphetamine-induced self-injurious behavior in mice. Behavioural Pharmacology, 18(3), 239–249.PubMedGoogle Scholar
  181. Mori, T., Ito, S., Kita, T., & Sawaguchi, T. (2004). Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. Journal of Pharmacological Sciences, 96(4), 459–464.PubMedGoogle Scholar
  182. Muehlmann, A. M., Brown, B. D., & Devine, D. P. (2008). Pemoline (2-amino-5-phenyl-1,3-oxazol-4-one)-induced self-injurious behavior: A rodent model of pharmacotherapeutic efficacy. The Journal of Pharmacology and Experimental Therapeutics, 324(1), 214–223.PubMedGoogle Scholar
  183. Muehlmann, A. M., & Devine, D. P. (2008). Glutamate-mediated neuroplasticity in an animal model of self-injurious behaviour. Behavioural Brain Research, 189(1), 32–40.PubMedGoogle Scholar
  184. Muehlmann, A. M., Kies, S. D., Turner, C. A., Wolfman, S., Lewis, M. H., & Devine, D. P. (2012). Self-injurious behaviour: Limbic dysregulation and stress effects in an animal model. Journal of Intellectual Disability Research, 56(5), 490–500.PubMedGoogle Scholar
  185. Muehlmann, A. M., Wilkinson, J. A., & Devine, D. P. (2011). Individual differences in vulnerability for self-injurious behavior: Studies using an animal model. Behavioural Brain Research, 217(1), 148–154.PubMedCentralPubMedGoogle Scholar
  186. Novak, M. A. (2003). Self-injurious behavior in rhesus monkeys: New insights into its etiology, physiology, and treatment. American Journal of Primatology, 59(1), 3–19.PubMedGoogle Scholar
  187. Nyhan, W. L. (1972). Behavioral phenotypes in organic genetic disease: Presidential address to the Society for Pediatric Research, May 1, 1971. Pediatric Research, 6(1), 1–9.PubMedGoogle Scholar
  188. Nyhan, W. L. (1973). The Lesch-Nyhan syndrome. Annual Review of Medicine, 24, 41–60.PubMedGoogle Scholar
  189. Nyhan, W. L. (1997). The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. Journal of Inherited Metabolic Disease, 20(2), 171–178.PubMedGoogle Scholar
  190. Nyhan, W. L., Johnson, H. G., Kaufman, I. A., & Jones, K. L. (1980). Serotonergic approaches to the modification of behavior in the Lesch-Nyhan syndrome. Applied Research in Mental Retardation, 1(1), 25–40.PubMedGoogle Scholar
  191. Oblak, A., Gibbs, T. T., & Blatt, G. J. (2009). Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Research, 2(4), 205–219.PubMedCentralPubMedGoogle Scholar
  192. Oliver, C., Sloneem, J., Hall, S., & Arron, K. (2009). Self-injurious behaviour in Cornelia de Lange syndrome: 1. Prevalence and phenomenology. Journal of Intellectual Disability Research, 53(7), 575–589.PubMedGoogle Scholar
  193. Oltras, C. M., Mora, F., & Vives, F. (1987). Beta-endorphin and ACTH in plasma: Effects of physical and psychological stress. Life Sciences, 40(17), 1683–1686.PubMedGoogle Scholar
  194. Orr, R. (1993). Age-related changes in stress experienced by families with a child who has developmental delays. Mental Retardation, 31(3), 171–176.PubMedGoogle Scholar
  195. Osman, O. T., & Loschen, E. L. (1992). Self-injurious behavior in the developmentally disabled: Pharmacologic treatment. Psychopharmacology Bulletin, 28(4), 439–449.PubMedGoogle Scholar
  196. Overhauser, J., Huang, X., Gersh, M., Wilson, W., McMahon, J., Bengtsson, U., et al. (1994). Molecular and phenotypic mapping of the short arm of chromosome 5: Sublocalization of the critical region for the cri-du-chat syndrome. Human Molecular Genetics, 3(2), 247–252.PubMedGoogle Scholar
  197. Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., et al. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124(6), 1533–1540.PubMedGoogle Scholar
  198. Parikh, M. S., Kolevzon, A., & Hollander, E. (2008). Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology, 18(2), 157–178.PubMedGoogle Scholar
  199. Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., et al. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 548–556.PubMedGoogle Scholar
  200. Peebles, K. A., & Price, T. J. (2012). Self-injurious behaviour in intellectual disability syndromes: Evidence for aberrant pain signalling as a contributing factor. Journal of Intellectual Disability Research, 56(5), 441–452.PubMedCentralPubMedGoogle Scholar
  201. Pfeffer, C. R., Jiang, H., & Domeshek, L. J. (1997). Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. Journal of Child and Adolescent Psychopharmacology, 7(3), 145–155.PubMedGoogle Scholar
  202. Piazza, C. C., Adelinis, J. D., Hanley, G. P., Goh, H., & Delia, M. D. (2000). An evaluation of the effects of matched stimuli on behaviors maintained by automatic reinforcement. Journal of Applied Behavior Analysis, 33(1), 13–27.PubMedCentralPubMedGoogle Scholar
  203. Piazza, C. C., Fisher, W. W., & Kahng, S. W. (1996). Sleep patterns in children and young adults with mental retardation and severe behavior disorders. Developmental Medicine and Child Neurology, 38(4), 335–344.PubMedGoogle Scholar
  204. Politte, L. C., & McDougle, C. J. (2014). Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl), 231(6), 1023–1036.Google Scholar
  205. Posey, D. J., Stigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. Journal of Clinical Investigation, 118(1), 6–14.PubMedCentralPubMedGoogle Scholar
  206. Potenza, M. N., Holmes, J. P., Kanes, S. J., & McDougle, C. J. (1999). Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study. Journal of Clinical Psychopharmacology, 19(1), 37–44.PubMedGoogle Scholar
  207. Privitera, M. D. (1997). Topiramate: A new antiepileptic drug. The Annals of Pharmacotherapy, 31(10), 1164–1173.PubMedGoogle Scholar
  208. Quine, L. (1991). Sleep problems in children with mental handicap. Journal of Mental Deficiency Research, 35(4), 269–290.PubMedGoogle Scholar
  209. Quine, S. (1993). Stressors experienced by relatives of patients in an innovative rehabilitation program. Health and Social Work, 18(2), 114–122.PubMedGoogle Scholar
  210. Ratey, J. J., Sovner, R., Mikkelsen, E., & Chmielinski, H. E. (1989). Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. The Journal of Clinical Psychiatry, 50(10), 382–384.PubMedGoogle Scholar
  211. Reisberg, B., & Gershon, S. (1979). Side effects associated with lithium therapy. Archives of General Psychiatry, 36(8), 879–887.PubMedGoogle Scholar
  212. Riblet, L. A., Taylor, D. P., Elson, M. S., & Stanton, H. C. (1982). Pharmacology and neurochemistry of buspirone. Journal of Clinical Psychiatry, 43(12), 11–16.PubMedGoogle Scholar
  213. Richardson, J. S., & Zaleski, W. A. (1983). Naloxone and self-mutilation. Biological Psychiatry, 18(1), 99–101.PubMedGoogle Scholar
  214. Richman, D. M., Barnard-Brak, L., Bosch, A., Thompson, S., Grubb, L., & Abby, L. (2013). Predictors of self-injurious behaviour exhibited by individuals with autism spectrum disorder. Journal of Intellectual Disability Research, 57(5), 429–439.PubMedGoogle Scholar
  215. Ricketts, R. W., Goza, A. B., Ellis, C. R., Singh, Y. N., Chambers, S., Singh, N. N., et al. (1994). Clinical effects of buspirone on intractable self-injury in adults with mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 33(2), 270–276.PubMedGoogle Scholar
  216. Roach, E. S., Delgado, M., Anderson, L., Iannaccone, S. T., & Burns, D. K. (1996). Carbamazepine trial for Lesch-Nyhan self-mutilation. Journal of Child Neurology, 11(6), 476–478.PubMedGoogle Scholar
  217. Roby-Brami, A., Bussel, B., Willer, J. C., & Le Bars, D. (1987). An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli: Probable involvement of a supraspinal loop. Brain, 110(6), 1497–1508.PubMedGoogle Scholar
  218. Rohatgi, S., Clark, D., Kline, A. D., Jackson, L. G., Pie, J., Siu, V., et al. (2010). Facial diagnosis of mild and variant CdLS: Insights from a dysmorphologist survey. American Journal of Medical Genetics, 152A(7), 1641–1653.PubMedGoogle Scholar
  219. Rojahn, J., Wilkins, J., Matson, J. L., & Boisjoli, J. (2010). A comparison of adults with intellectual disabilities with and without ASD on parallel measures of challenging behaviour: The behavior problems inventory-01 (BPI-01) and Autism spectrum disorders-behavior problems for intellectually disabled adults (ASD-BPA). Journal of Applied Research in Intellectual Disabilities, 23(2), 179–185.Google Scholar
  220. Ruedrich, S., Swales, T. P., Fossaceca, C., Toliver, J., & Rutkowski, A. (1999). Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: A retrospective review. Journal of Intellectual Disability Research, 43(2), 105–111.PubMedGoogle Scholar
  221. Ruedrich, S. L., Swales, T. P., Rossvanes, C., Diana, L., Arkadiev, V., & Lim, K. (2008). Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities. Journal of Intellectual Disability Research, 52(2), 132–140.PubMedGoogle Scholar
  222. Saito, Y., & Takashima, S. (2000). Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain and Development, 22, S122–S131.PubMedGoogle Scholar
  223. Sampat, R., Fu, R., Larovere, L. E., Torres, R. J., Ceballos-Picot, I., Fischbach, M., et al. (2011). Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants. Human Genetics, 129(1), 71–78.PubMedCentralPubMedGoogle Scholar
  224. Sandman, C. A., Barron, J. L., Chicz-DeMet, A., & DeMet, E. M. (1990). Plasma B-endorphin levels in patients with self-injurious behavior and stereotypy. American Journal of Mental Retardation, 95(1), 84–92.PubMedGoogle Scholar
  225. Sandman, C. A., Datta, P. C., Barron, J., Hoehler, F. K., Williams, C., & Swanson, J. M. (1983). Naloxone attenuates self-abusive behavior in developmentally disabled clients. Applied Research in Mental Retardation, 4(1), 5–11.PubMedGoogle Scholar
  226. Sandman, C. A., Hetrick, W., Taylor, D. V., & Chicz-DeMet, A. (1997). Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. American Journal of Mental Retardation, 102(2), 182–199.PubMedGoogle Scholar
  227. Sandman, C. A., Spence, M. A., & Smith, M. (1999). Proopiomelanocortin (POMC) disregulation and response to opiate blockers. Mental Retardation and Developmental Disabilities Research Reviews, 5(4), 314–321.Google Scholar
  228. Sandman, C. A., Touchette, P. E., Marion, S. D., & Chicz-DeMet, A. (2008). The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Developmental Psychobiology, 50(7), 680–689.PubMedCentralPubMedGoogle Scholar
  229. Sassi, R. B., & Soares, J. C. (2002). Neural circuitry and signaling in bipolar disorder. In G. B. Kaplan & R. P. Hammer (Eds.), Brain circuitry and signaling in psychiatry (pp. 179–200). Washington, DC: American Psychiatric Publishing Inc.Google Scholar
  230. Scahill, L., Aman, M. G., McDougle, C. J., Arnold, L. E., McCracken, J. T., Handen, B., et al. (2009). Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 39(5), 720–729.PubMedGoogle Scholar
  231. Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. The Journal of Pediatrics, 58, 315–320.PubMedGoogle Scholar
  232. Schroeder, S. R., Oster-Granite, M. L., Berkson, G., Bodfish, J. W., Breese, G. R., Cataldo, M. F., et al. (2001). Self-injurious behavior: Gene–brain–behavior relationships. Mental Retardation and Developmental Disabilities Research Reviews, 7(1), 3–12.PubMedGoogle Scholar
  233. Schroeder, S. R., Schroeder, C. S., Smith, B., & Dalldorf, J. (1978). Prevalence of self-injurious behaviors in a large state facility for the retarded: A three-year follow-up study. Journal of Autism and Childhood Schizophrenia, 8(3), 261–269.PubMedGoogle Scholar
  234. Shakya, D. R., Shyangwa, P. M., Pandey, A. K., Subedi, S., & Yadav, S. (2010). Self injurious behavior in temporal lobe epilepsy. Journal of the Nepal Medical Association, 49(179), 239–242.PubMedGoogle Scholar
  235. Shapira, N. A., Lessig, M. C., Murphy, T. K., Driscoll, D. J., & Goodman, W. K. (2002). Topiramate attenuates self-injurious behaviour in Prader-Willi syndrome. The International Journal of Neuropsychopharmacology, 5(2), 141–145.PubMedGoogle Scholar
  236. Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(8), 1472–1477.PubMedGoogle Scholar
  237. Siegel, M., Milligan, B., Robbins, D., & Prentice, G. (2012). Electroconvulsive therapy in an adolescent with autism and bipolar I disorder. The Journal of ECT, 28(4), 252–255.PubMedGoogle Scholar
  238. Sigafoos, J., O’Reilly, M., Ma, C. H., Edrisinha, C., Cannella, H., & Lancioni, G. E. (2006). Effects of embedded instruction versus discrete-trial training on self-injury, correct responding, and mood in a child with autism. Journal of Intellectual and Developmental Disability, 31(4), 196–203.PubMedGoogle Scholar
  239. Simeon, D., Stein, D. J., Gross, S., Islam, N., Schmeidler, J., & Hollander, E. (1997). A double-blind trial of fluoxetine in pathologic skin picking. The Journal of Clinical Psychiatry, 58(8), 341–347.PubMedGoogle Scholar
  240. Singh, N. N., & Aman, M. G. (1981). Effects of thioridazine dosage on the behavior of severely mentally retarded persons. American Journal of Mental Deficiency, 85(6), 580–587.PubMedGoogle Scholar
  241. Skinner, B. F. (1938). The behavior of organisms: An experimental analysis. Oxford, England: Appleton-Century.Google Scholar
  242. Smith, R. G. (2011). Developing antecedent interventions for problem behavior. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 297–316). New York: Guilford Press.Google Scholar
  243. Snyder, R., Turgay, A., Aman, M., Binder, C., Fisman, S., & Carroll, A. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1026–1036.PubMedGoogle Scholar
  244. Sohanpal, S. K., Deb, S., Thomas, C., Soni, R., Lenotre, L., & Unwin, G. (2007). The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: A systematic review. Journal of Intellectual Disability Research, 51(10), 750–765.PubMedGoogle Scholar
  245. Sovner, R. (1986). Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacology Bulletin, 22(4), 1055–1059.PubMedGoogle Scholar
  246. Sovner, R., Fox, C. J., Lowry, M. J., & Lowry, M. A. (1993). Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. Journal of Intellectual Disability Research, 37(3), 301–311.PubMedGoogle Scholar
  247. Sprague, J. R., & Horner, R. H. (1995). Functional assessment and intervention in community settings. Mental Retardation and Developmental Disabilities Research Reviews, 1(2), 89–93.Google Scholar
  248. Sprague, R. L., & Werry, J. S. (1971). Methodology of psychopharmacological studies with the retarded. International Review of Research in Mental Retardation, 5, 147–219.Google Scholar
  249. Stein, D. J., Keating, J., Zar, H. J., & Hollander, E. (1994). A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences, 6(1), 23–29.PubMedGoogle Scholar
  250. Sterling-Turner, H. E., & Jordan, S. S. (2007). Interventions addressing transition difficulties for individuals with autism. Psychology in the Schools, 44(7), 681–690.Google Scholar
  251. Stigler, K. A., Diener, J. T., Kohn, A. E., Li, L., Erickson, C. A., Posey, D. J., et al. (2009). Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger’s disorder: A 14-week, prospective, open-label study. Journal of Child and Adolescent Psychopharmacology, 19(3), 265–274.PubMedCentralPubMedGoogle Scholar
  252. Stigler, K. A., Potenza, M. N., Posey, D. J., & McDougle, C. J. (2004). Weight gain associated with atypical antipsychotic use in children and adolescents: Prevalence, clinical relevance, and management. Pediatric Drugs, 6(1), 33–44.PubMedGoogle Scholar
  253. Stout, R. J. (1990). Fluoxetine for the treatment of compulsive facial picking. American Journal of Psychiatry, 147(3), 370.PubMedGoogle Scholar
  254. Stout, J. T., & Caskey, C. T. (1985). HPRT: Gene structure, expression, and mutation. Annual Review of Genetics, 19, 127–148.PubMedGoogle Scholar
  255. Svendsen, C. N., Froimowitz, M., Hrbek, C., Campbell, A., Kula, N., Baldessarini, R. J., et al. (1988). Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology, 27(11), 1117–1124.PubMedGoogle Scholar
  256. Symons, F. J., Butler, M. G., Sanders, M. D., Feurer, I. D., & Thompson, T. (1999). Self-injurious behavior and Prader-Willi syndrome: Behavioral forms and body locations. American Journal of Mental Retardation, 104(3), 260–269.PubMedGoogle Scholar
  257. Symons, F. J., & Danov, S. E. (2005). A prospective clinical analysis of pain behavior and self-injurious behavior. Pain, 117(3), 473–477.PubMedGoogle Scholar
  258. Tate, B. G., & Baroff, G. S. (1973). Aversive control of self-Injurious behavior in a psychotic boy. In J. M. Stedman, W. F. Patton, & K. F. Walton (Eds.), Clinical studies in behavior therapy with children, adolescents and their families (pp. 352–360). Springfield, IL: Charles C. Thomas Publisher.Google Scholar
  259. Taylor, D. V., Rush, D., Hetrick, W. P., & Sandman, C. A. (1993). Self-injurious behavior within the menstrual cycle of women with mental retardation. American Journal of Mental Retardation, 97(6), 659–664.PubMedGoogle Scholar
  260. Thompson, R. H., & Borrero, J. C. (2011). Direct observation. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 191–205). New York: Guilford Press.Google Scholar
  261. Tiefenbacher, S., Novak, M. A., Lutz, C. K., & Meyer, J. S. (2005). The physiology and neurochemistry of self-injurious behavior: A nonhuman primate model. Frontiers in Bioscience, 10, 1–11.PubMedGoogle Scholar
  262. Tsiouris, J. A., Cohen, I. L., Patti, P. J., & Korosh, W. M. (2003). Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior. The Journal of Clinical Psychiatry, 64(9), 1081–1090.PubMedGoogle Scholar
  263. Tyrer, S. P., Walsh, A., Edwards, D. E., Berney, T. P., & Stephens, D. A. (1984). Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 8(4), 751–755.PubMedGoogle Scholar
  264. Van der Zee, S. P., Schretlen, E. D., & Monnens, L. A. (1968). Megaloblastic anaemia in the Lesch-Nyhan syndrome. Lancet, 1(7557), 1427.PubMedGoogle Scholar
  265. Van Erp, A. M., & Miczek, K. A. (2000). Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. Journal of Neuroscience, 20(24), 9320–9325.PubMedGoogle Scholar
  266. Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., et al. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics, 14(4), 1104–1106.PubMedGoogle Scholar
  267. Veenstra-VanderWeele, J., & Anderson, G. M. (2011). The serotonin system in autism. In E. Hollander, A. Kolevzon, & J. T. Coyle (Eds.), Textbook of autism spectrum disorders (pp. 315–322). Washington, DC: American Psychiatric Publishing Inc.Google Scholar
  268. Vestergaard, P., Amdisen, A., & Schou, M. (1980). Clinically significant side effects of lithium treatment: A survey of 237 patients in long-term treatment. Acta Psychiatrica Scandinavica, 62(3), 193–200.PubMedGoogle Scholar
  269. Vollmer, T. R., Iwata, B. A., Zarcone, J. R., & Smith, R. G. (1993). The role of attention in the treatment of attention-maintained self-injurious behavior: Noncontingent reinforcement and differential reinforcement of other behavior. Journal of Applied Behavior Analysis, 26(1), 9–21.PubMedCentralPubMedGoogle Scholar
  270. Vollmer, T. R., Marcus, B. A., & LeBlanc, L. (1994). Treatment of self-injury and hand mouthing following inconclusive functional analyses. Journal of Applied Behavior Analysis, 27(2), 331–344.PubMedCentralPubMedGoogle Scholar
  271. Wachtel, L. E., Contrucci-Kuhn, S. A., Griffin, M., Thompson, A., Dhossche, D. M., & Reti, I. M. (2009). ECT for self-injury in an autistic boy. European Child and Adolescent Psychiatry, 18(7), 458–463.PubMedGoogle Scholar
  272. Wachtel, L. E., & Dhossche, D. M. (2010). Self-injury in autism as an alternate sign of catatonia: Implications for electroconvulsive therapy. Medical Hypotheses, 75(1), 111–114.PubMedGoogle Scholar
  273. Wachtel, L. E., Griffin, M., & Reti, I. M. (2010). Electroconvulsive therapy in a man with autism experiencing severe depression, catatonia, and self-injury. The Journal of ECT, 26(1), 70–73.PubMedGoogle Scholar
  274. Wallis, C. (2009). Respiratory health of people with profound intellectual and multiple disabilities. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 186–201). Hoboken: Wiley.Google Scholar
  275. Walters, A. S., Barrett, R. P., Feinstein, C., Mercurio, A., & Hole, W. T. (1990). A case report of naltrexone treatment of self-injury and social withdrawal in autism. Journal of Autism and Developmental Disorders, 20(2), 169–176.PubMedGoogle Scholar
  276. Watt-Smith, P. (2009). Dental care and oral health. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 202–235). Hoboken: Wiley.Google Scholar
  277. West, S. A., Keck, P. E., & Mcelroy, S. L. (1995). Oral loading doses in the valproate treatment of adolescents with mixed bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 5(3), 225–231.Google Scholar
  278. Willemsen-Swinkels, S. H., Buitelaar, J. K., Nijhof, G. J., & van Engeland, H. (1995). Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Archives of General Psychiatry, 52(9), 766–773.PubMedGoogle Scholar
  279. Willer, J. C., Dehen, H., & Cambier, J. (1981). Stress-induced analgesia in humans: Endogenous opioids and naloxone-reversible depression of pain reflexes. Science, 212(4495), 689–691.PubMedGoogle Scholar
  280. Williams, K., Wheeler, D. M., Silove, N., & Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, (8), CD004677. doi: 10.1002/14651858.CD004677.pub2.
  281. Wilson, J. M., Young, A. B., & Kelley, W. N. (1983). Hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular basis of the clinical syndromes. The New England Journal of Medicine, 309(15), 900–910.PubMedGoogle Scholar
  282. Wink, L. K., Erickson, C. A., & McDougle, C. J. (2010). Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treatment Options in Neurology, 12(6), 529–538.PubMedGoogle Scholar
  283. Wolff, J. J., Hazlett, H. C., Lightbody, A. A., Reiss, A. L., & Piven, J. (2013). Repetitive and self-injurious behaviors: Associations with caudate volume in autism and fragile X syndrome. Journal of Neurodevelopmental Disorders, 5(1), 12.PubMedCentralPubMedGoogle Scholar
  284. Wong, D. F., Harris, J. C., Naidu, S., Yokoi, F., Marenco, S., Dannals, R. F., et al. (1996). Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proceedings of the National Academy of Sciences of the United States of America, 93(11), 5539–5543.PubMedCentralPubMedGoogle Scholar
  285. Zhang, W., & Bymaster, F. P. (1999). The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology (Berl), 141(3), 267–278.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Noha F. Minshawi
    • 1
  • Sarah Hurwitz
    • 2
  • Danielle Morriss
    • 3
  • Christopher J. McDougle
    • 4
  1. 1.Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Department of PsychiatryIndiana University School of MedicineIndianapolisUSA
  2. 2.School of EducationIndiana UniversityBloomingtonUSA
  3. 3.Department of Psychiatry and Human BehaviorWarren Alpert Medical School of Brown UniversityProvidenceUSA
  4. 4.Departments of Psychiatry and Pediatrics, Lurie Center for Autism, Massachusetts General Hospital and MassGeneral Hospital for ChildrenHarvard Medical SchoolLexingtonUSA

Personalised recommendations